Metacrine, Inc. - Common Stock (NQ:MTCR)
All News about Metacrine, Inc. - Common Stock
From Metacrine, Inc.
Via GlobeNewswire
Via Benzinga
Equillium Buys Inflammatory Bowel Disease Player In All-Stock Deal ↗
September 07, 2022
Via Benzinga
Metacrine Reports Third-Quarter 2022 Results
November 14, 2022
From Metacrine, Inc.
Via GlobeNewswire
Via Benzinga
Via Benzinga
Equillium to Acquire Metacrine in All-Stock Transaction
September 06, 2022
From Equillium, Inc.
Via Business Wire
Wingstop, Akamai Initiations Among Today's Top Calls On Wall Street ↗
December 29, 2021
Via Talk Markets